Rubicon Organics Inc. Share Price Canadian Securities Exchange
Equities
ROMJ
CA78112W1005
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.1 CAD | +7.89% | +15.82% | +13.26% |
28/03 | Rubicon Organics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
28/03 | Transcript : Rubicon Organics Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Sales 2024 * | 44.69M 32.64M 2.73B | Sales 2025 * | 48.36M 35.33M 2.95B | Capitalization | 20.79M 15.19M 1.27B |
---|---|---|---|---|---|
Net income 2024 * | -1M -730K -60.99M | Net income 2025 * | - 0 0 | EV / Sales 2024 * | 0.47 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.43 x |
P/E ratio 2024 * |
-18.5
x | P/E ratio 2025 * |
-37
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 45.84% |
Latest transcript on Rubicon Organics Inc.
1 day | +7.89% |
Managers | Title | Age | Since |
---|---|---|---|
Margaret Brodie
CEO | Chief Executive Officer | 46 | 10/16/10 |
Janis Risbin
DFI | Director of Finance/CFO | 44 | - |
Peter Dierx
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Donnan
BRD | Director/Board Member | 68 | 24/19/24 |
Director/Board Member | 60 | 20/23/20 | |
Margaret Brodie
CEO | Chief Executive Officer | 46 | 10/16/10 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-.--% | 339M | |
+36.08% | 281M | |
+34.57% | 263M | |
+43.60% | 187M | |
+164.52% | 150M | |
-28.57% | 121M | |
-35.55% | 133M | |
+47.83% | 134M | |
-7.69% | 80.17M |
- Stock Market
- Equities
- ROMJ Stock
- ROMJ Stock